Back to drug safety directory
Estrogen (HRT, contraception, gender-affirming care)Reviewed May 16, 2026

Estradiol (Estrace) and Ketamine Therapy | Tovani Health

Estrace (Estradiol) (also: Climara, Vivelle-Dot, Estring)Estrogen (HRT, contraception, gender-affirming care)

Verdict at Tovani Health

Fully compatible with KAP; no meaningful interaction.

Estradiol and ketamine have no clinically significant interaction. Whether you are on estradiol for menopausal HRT, hormonal contraception, or gender-affirming care, KAP can proceed without medication changes.

If you take Estrace regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Estrace interacts with ketamine

Estradiol binds estrogen receptors with downstream genomic effects. No overlap with ketamine pharmacology.

What we do at intake

Continue as normal. Disclose form (pill, patch, ring, injection) for completeness.

Bottom line

Estradiol and ketamine have no clinically significant interaction. Whether you are on estradiol for menopausal HRT, hormonal contraception, or gender-affirming care, KAP can proceed without medication changes.

Frequently Asked Questions

Does estradiol interact with ketamine in any way?

Not clinically. Continue your regimen as normal.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Estrace (Estradiol) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Sources

The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.

  1. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI.. Clinical Pharmacokinetics. 2016. PMID: 27028535

    Comprehensive clinical pharmacokinetics/pharmacodynamics review of ketamine including CYP-mediated drug interactions (CYP3A4, CYP2B6).

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.